VERU INC. Depreciation
VERU INC. (VERU) reported Depreciation of $28.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-10
- VERU INC. depreciation for the quarter ending 2026-06-30 was $28.00K, a 3.45% decline year-over-year.
- VERU INC. depreciation for the quarter ending 2026-03-31 was $28.00K, a 3.45% decline year-over-year.
- VERU INC. depreciation for the quarter ending 2025-12-31 was $28.00K, a 3.45% decline year-over-year.
- VERU INC. depreciation for the quarter ending 2025-09-30 was $12.00K, a 140.00% increase year-over-year.
- VERU INC. depreciation for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- VERU INC. depreciation for fiscal 2024 was $100.00K, a 50.00% decline from fiscal 2023.
- VERU INC. depreciation for fiscal 2023 was $200.00K, a 44.93% increase from fiscal 2022.
- VERU INC. depreciation for fiscal 2022 was $138.00K, a 40.82% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $28.00K 10-Q · filed 2026-08-10 | $56.00K derived: sum of 2 quarters · filed 2026-08-10 | $85.00K 10-Q · filed 2026-08-10 | $96.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2026-03-31 | $28.00K 10-Q · filed 2026-05-13 | $56.00K derived: sum of 2 quarters · filed 2026-05-13 | $68.00K derived: sum of 3 quarters · filed 2026-05-13 | $97.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-12-31 | $28.00K 10-Q · filed 2026-02-11 | $40.00K derived: sum of 2 quarters · filed 2026-02-11 | $69.00K derived: sum of 3 quarters · filed 2026-08-10 | $98.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-09-30 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $41.00K derived: sum of 2 quarters · filed 2026-08-10 | $70.00K derived: sum of 3 quarters · filed 2026-08-10 | $100.00K 10-K · filed 2025-12-17 | |||
| 2025-06-30 | $29.00K 10-Q · filed 2026-08-10 | $58.00K derived: sum of 2 quarters · filed 2026-08-10 | $88.00K 10-Q · filed 2026-08-10 | $92.00K derived: sum of 4 quarters · filed 2026-08-10 | |||
| 2025-03-31 | $29.00K 10-Q · filed 2026-05-13 | $59.00K 10-Q · filed 2025-05-08 | $63.00K derived: sum of 3 quarters · filed 2026-05-13 | $95.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $29.00K 10-Q · filed 2026-02-11 | $34.00K derived: sum of 2 quarters · filed 2026-02-11 | $66.00K derived: sum of 3 quarters · filed 2026-02-11 | $98.00K derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-09-30 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-17 | $37.00K derived: sum of 2 quarters · filed 2025-12-17 | $69.00K derived: sum of 3 quarters · filed 2025-12-17 | $100.00K 10-K · filed 2025-12-17 | $300.00K 10-K · filed 2024-12-16 | ||
| 2024-06-30 | $32.00K 10-Q · filed 2025-08-12 | $65.00K 10-Q · filed 2024-08-08 | $197.00K 10-Q · filed 2024-08-08 | $95.00K 10-Q · filed 2025-08-12 | $150.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $32.00K 10-Q · filed 2025-05-08 | $66.00K 10-Q · filed 2024-05-08 | $64.00K 10-Q · filed 2025-05-08 | $132.00K 10-Q · filed 2024-05-08 | $118.00K derived: sum of 3 quarters · filed 2025-05-08 | $171.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $32.00K 10-Q · filed 2025-02-13 | $66.00K 10-Q · filed 2024-04-01 | $86.00K derived: sum of 2 quarters · filed 2025-02-13 | $139.00K derived: sum of 3 quarters · filed 2025-02-13 | $184.00K derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-09-30 | $54.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-12-16 | $107.00K derived: sum of 2 quarters · filed 2024-12-16 | $152.00K derived: sum of 3 quarters · filed 2024-12-16 | $200.00K 10-K · filed 2024-12-16 | $198.00K 10-K · filed 2023-12-08 | ||
| 2023-06-30 | $53.00K 10-Q · filed 2024-08-08 | $146.00K 10-Q · filed 2024-08-08 | $146.00K 10-Q/A · filed 2023-11-15 | $187.00K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | $45.00K 10-Q · filed 2024-05-08 | $48.00K 10-Q · filed 2023-05-11 | $93.00K 10-Q · filed 2024-05-08 | $134.00K derived: sum of 3 quarters · filed 2024-05-08 | $173.00K derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $45.00K 10-Q · filed 2024-04-01 | $89.00K derived: sum of 2 quarters · filed 2024-04-01 | $128.00K derived: sum of 3 quarters · filed 2024-04-01 | $158.00K derived: sum of 4 quarters · filed 2024-04-01 | |||
| 2022-09-30 | $44.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $83.00K derived: sum of 2 quarters · filed 2024-04-01 | $113.00K derived: sum of 3 quarters · filed 2024-04-01 | $138.00K 10-K/A · filed 2024-04-01 | |||
| 2022-06-30 | $39.00K 10-Q/A · filed 2023-11-15 | $69.00K derived: sum of 2 quarters · filed 2023-11-15 | $94.00K 10-Q/A · filed 2023-11-15 | $117.00K derived: sum of 4 quarters · filed 2023-11-15 | |||
| 2022-03-31 | $30.00K 10-Q · filed 2023-05-11 | $55.00K 10-Q · filed 2023-05-11 | $78.00K derived: sum of 3 quarters · filed 2023-05-11 | $99.00K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $25.00K 10-Q · filed 2023-02-09 | $48.00K derived: sum of 2 quarters · filed 2023-02-09 | $69.00K derived: sum of 3 quarters · filed 2023-02-09 | $91.00K derived: sum of 4 quarters · filed 2023-02-09 | |||
| 2021-09-30 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | $44.00K derived: sum of 2 quarters · filed 2022-12-05 | $66.00K derived: sum of 3 quarters · filed 2022-12-05 | $98.00K 10-K · filed 2022-12-05 | |||
| 2021-06-30 | $21.00K 10-Q · filed 2022-08-11 | $43.00K derived: sum of 2 quarters · filed 2022-08-11 | $75.00K 10-Q · filed 2022-08-11 | ||||
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-12 | $54.00K 10-Q · filed 2022-05-12 | |||||
| 2020-12-31 | $32.00K 10-Q · filed 2022-02-09 | ||||||
| 2020-09-30 | $146.00K 10-K · filed 2021-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |